SAGE Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
ShortableYes
OptionableYes
Short Percent Of Outstanding Shares6.81
Short Percent Of Float7.72
Shares Outstanding61.48M
Shares Float54.22M
Shares Short4.17M
Short Ratio1.54
7.72%
Short % of Float6.81%
Short % of Shares OutstandingMarket Insider SAGE
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Major Holders Summary
11.99% Percentage of Shares held by All Insiders
87.94% Percentage of Shares held by All Institutions
99.92% Percentage of Float held by Institutions
243
Number of Institutions Holding SharesInstitutional Ownership
About 87.94% of SAGE shares are held by financial institutions. CAPITAL FUND MANAGEMENT S.A. is the top corporate investor, holding 133.15K shares valued at $2.50M. A 0.22% stake in Sage Therapeutics, Inc. is owned by the company. FMR LLC owns 5.87M shares valued at $109.97M, which translates its holding of 9.81% of the stake in the company.
SAGE Insiders
Among the SAGE insiders holding of 11.99% of the stake in company, STARR KEVIN P, director, holds the largest shares of 320.66K. ROBICHAUD ALBERT, Chief Scientific Officer, is the second largest SAGE insider with ownership of 136.4K shares. PAUL STEVEN M, director, stands third with possession of 122.4K shares of that stake.
Buying/Selling by Insiders
Frequently Asked Questions
How many institutions own SAGE stock?
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SAGE shares is 243, representing 87.94% of the company's common stock.
Who are the major shareholders selling Sage Therapeutics, Inc. stock?
EASTERLY INVESTMENT PARTNERS LLC, in the last quarter, reduced its stake in SAGE by -10.63% restricting it's holding to 109.6 thousand shares of worth nearly $2.05M. CREDIT SUISSE AG/ also lessened -8.26% of the SAGE shares from its portfolio, reducing its holding to 103.41 thousand shares of worth $1.94M. BAILLIE GIFFORD & CO also shunned SAGE shares holding by -4.66% last quarter which brought its holding to 80.82 thousand shares worth $1.51M.
Investors who are buying SAGE stock?
As per its latest 13F filing, CAPITAL FUND MANAGEMENT S.A. increased its stake in SAGE by 82.64% in the last quarter. The institutional holder raised its holding to 133.15 thousand shares having worth more than $2.50M. FMR LLC also added 7.04% more shares of SAGE to its portfolio, raising its holding to 5.87 million shares of worth $109.97M. VANGUARD GROUP INC also increased its SAGE shares holding by 8.12% which brought its holding to 5.75 million shares worth $107.78M.
SAGE's major insiders: who are they?
The insider with the most stakes in SAGE is STARR KEVIN P , director at the company. Additionally, SAGE stock is highly held by Chief Scientific Officer Robichaud Albert and director PAUL STEVEN M among others.
Did an insider recently sell SAGE stock?
Company executives, directors, and other insiders own 11.99% percent of Sage Therapeutics, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which SAGE insiders have sold stock, totaling 0 shares. Insiders that have sold shares include JONAS JEFFREY M, FRATES JAMES M, and CLOONAN MICHAEL.
Which insider recently purchased SAGE stock?
There have been 0 transaction(s) during the past 6-months in which Sage Therapeutics, Inc. insiders have bought stock, totalling 0 shares
How much of SAGE does insiders own?
Around 0 Sage Therapeutics, Inc. shares are held by insiders, which represents about 11.99% of SAGE stock.
Who is the insider with the largest stake?
SAGE director, STARR KEVIN P holds the largest portfolio of the company's shares. SAGE shares owned by STARR total nearly 320.66 thousand.
Which institution holds the most shares in SAGE?
CAPITAL FUND MANAGEMENT S.A. is the largest institutional owner in SAGE which holds 133.15 thousand shares worth $2.50M or 0.22% of the total SAGE shares outstanding followed by FMR LLC with ownership of 5.87 million shares representing 9.81% of the SAGE ownership. VANGUARD GROUP INC is the third largest stakeholder with 5.75 million shares or 9.61% of the ownership worth more than $107.78M.
Is Sage Therapeutics, Inc. stock optionable?
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SAGE is concerned, it is a stock which is optionable.
Is there a short position on SAGE's shares?
Number of SAGE shares short is 4.17M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
About how many outstanding SAGE shares are there?
As of today, 61.48M shares of SAGE are outstanding.
Is there many float in SAGE stock?
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SAGE has 54.22M shares in float.
SAGE short ratio: what is it?
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SAGE is 1.54.